Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer’s Disease

As the focus of Alzheimer’s disease (AD) therapeutic development shifts to the early stages of the disease, the clinical endpoints used in drug trials, and how these might translate into clinical practice, are of increasing importance. The clinical meaningfulness of trial outcome measures is often u...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, S., Cummings, J., Knox, S., Potashman, M., Harrison, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843702/
https://www.ncbi.nlm.nih.gov/pubmed/35841252
http://dx.doi.org/10.14283/jpad.2022.41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843702/
https://www.ncbi.nlm.nih.gov/pubmed/35841252
http://dx.doi.org/10.14283/jpad.2022.41

Ejemplares similares